Moreover, we demonstrated that CD49dhi T cell subsets obtained from DMD patients have a higher in vitro migration capacity across endothelial layers and through fibronectin, when compared to CD49dlow T subpopulations (Pinto-Mariz et al., 2015). The gene discussed is FN1; the disease is Duchenne muscular dystrophy.